Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
CARD14 encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Zusätzlich bieten wir Ihnen CARD14 Proteine (6) und und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 59 products:
Human Polyclonal CARD14 Primary Antibody für WB - ABIN528893
Huh, Kim, Kim, Song, Jung, Jeong, Lee, Kim, Lee, An: Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. in British journal of cancer 2013
Results identified RNF7 (zeige RNF7 Antikörper) to interact with CARMA2 regulating its NF-kappaB (zeige NFKB1 Antikörper)-activating capacity. Mechanistically, RNF7 (zeige RNF7 Antikörper) influences CARMA2 signaling by regulating the ubiquitination state of MALT1 (zeige MALT1 Antikörper) and the NF-kappaB (zeige NFKB1 Antikörper)-regulatory molecule NEMO (zeige IKBKG Antikörper). Interestingly, CARMA2short (CARMA2sh) mutants associated with psoriasis susceptibility escape the negative control exerted by RNF7 (zeige RNF7 Antikörper).
The serine/threonine kinase (zeige TLK2 Antikörper) ULK2 (zeige ULK2 Antikörper) binds to and phosphorylates CARMA2sh.
MALT1 (zeige MALT1 Antikörper) deficiency or pharmacological inhibition of MALT1 (zeige MALT1 Antikörper) catalytic activity inhibits pathogenic mutant CARD14-induced cytokine and chemokine (zeige CCL1 Antikörper) expression in human primary keratinocytes.
CARD14/MALT1 (zeige MALT1 Antikörper)-mediated signaling in keratinocytes has a role in psoriasis [review]
The results indicate that the common CARD14 p.Arg820Trp variant might have a significant effect on the response to anti-TNF (zeige TNF Antikörper) therapies among patients with psoriasis. In addition, rare CARD14 missense variants could also predispose to a better response.
Our findings, combined with the published literature, suggest that Pityriasis Rubra Pilaris Type V, both familial and sporadic, can be caused by CARD14 mutations.
Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10 (zeige BCL10 Antikörper)-MALT1 (zeige MALT1 Antikörper)-dependent NF-kappaB (zeige NFKB1 Antikörper) activation
genetic evidence suggests association of the CARD14 single nucleotide polymorphism rs11652075 and other rare mutations in this gene with psoriasis. To assess whether combined data support the relationship between CARD14 rs11652075 and susceptibility to this disease, we conducted a meta-analysis. Our results demonstrate a significant association between the CARD14 rs11652075 polymorphism and psoriasis.
The authors observations provide further insights into the genetics of psoriasis and functional information on novel CARD14 mutational variants seen in cases from Tunisia and other populations.
Genetic interactions of SNPs in CARD14, SENP1 (zeige SENP1 Antikörper) and VEGFA (zeige VEGFA Antikörper) might represent a functional mechanism in the pathogenesis of high altitude polycythemia.
in experimental models of psoriasis induced by either imiquimod cream or recombinant IL-23 (zeige IL23A Antikörper) injection, the psoriasiform skin inflammation was abrogated in Card14(-/-) mice
This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants.
CARD-containing MAGUK protein 2
, bcl10-interacting maguk protein 2
, card-maguk protein 2
, carma 2
, caspase recruitment domain-containing protein 14
, bcl10-interacting MAGUK protein 2